欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4937/001
药品名称Sitagliptine CF 25 mg, filmomhulde tabletten
活性成分
    • SITAGLIPTIN hydrochloride 25.0 mg
剂型Film-coated tablet
上市许可持有人Centrafarm B.V. Van de Reijstraat 31E 4814 NE Breda The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Sitagliptine CF 25 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
      Sitagliptin STADA 25 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Germany (DE)
      Sitagliptin STADA 25 mg Filmtabletten
    • Denmark (DK)
    • Belgium (BE)
      Sitagliptin EG 25 mg filmomhulde tabletten
许可日期2021/09/08
最近更新日期2024/02/23
药物ATC编码
    • A10BH01 sitagliptin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase